Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | USP9X | Q93008 | 3/20 | 0.39 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | FABP6 | P51161 | 1/20 | 0.36 |
| ▸ | QPCT | Q16769 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL70215 | 0.87 | ALDH1A1 (0.62) | ALDH1A1GAAHSD17B10MAPTPDE3B | |
| SCHEMBL31208205 | 0.83 | ALDH1A1 (0.57) | ALDH1A1GAAHSD17B10MAPTPDE3B | |
| SCHEMBL18521857 | 0.81 | GAA (0.55) | ALDH1A1GAAHSD17B10MAPTPDE3B | |
| SCHEMBL23437838 | 0.79 | ALDH1A1 (0.57) | ALDH1A1GAAHSD17B10MAPTPDE3B | |
| SCHEMBL14924059 | 0.77 | MAPT (0.50) | ALDH1A1GAAHSD17B10MAPTPDE3B | |
| SCHEMBL1744600 | 0.75 | PTGS1 (0.59) | GAAMAPTKDM4EPTGS1PTGS2 | |
| SCHEMBL20559648 | 0.75 | PTGS1 (0.59) | GAAMAPTKDM4EPTGS1PTGS2 | |
| SCHEMBL3669879 | 0.75 | PTGS1 (0.59) | GAAMAPTKDM4EPTGS1PTGS2 | |
| SCHEMBL2933658 | 0.74 | ALDH1A1 (1.00) | ALDH1A1GAAHSD17B10MAPTPDE3B | |
| SCHEMBL30343092 | 0.74 | GAA (0.62) | ALDH1A1GAAHSD17B10MAPTPDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1345911-B1 | PROCESS FOR PREPARING 2-METHOXY-4-METHYL-6-METHYLAMINO-1,3,5-TRIAZINE | DEGUSSA (DE) | 2004-05-26 | — | — | EP | claimed |
| EP-1345911-A2 | PROCESS FOR PREPARING 2-METHOXY-4-METHYL-6-METHYLAMINO-1,3,5-TRIAZINE | Degussa AG (DE) | 2003-09-24 | — | — | EP | claimed |
| WO-2002051817-A2 | PROCESS FOR PREPARING 2-METHOXY-4-METHYL-6-METHYLAMINO-1,3,5-TRIAZINE | DEGUSSA AG (DE) | 2002-07-04 | — | — | WO | claimed |
| US-6342600-B1 | Process for preparing 2-methoxy-4-methyl-6-methylamino-1,3,5-triazine | SKW T OSTBERG AKTIENGESELLSCHAFT (DE) | 2002-01-29 | — | — | US | claimed |
| US-12427506-B1 | Method for carbon dioxide fixation using a palladium-doped nitrogen-rich organic framework catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-09-30 | — | — | US | disclosed |
| US-12381458-B2 | Method for producing a lamination stack, lamination stack and electric machine | THYSSENKRUPP STEEL EUROPE AG (DE) | 2025-08-05 | — | — | US | disclosed |
| EP-4492652-A1 | IMPROVEMENTS IN THE IN-LINE PROCESSING PROCESS OF COATED ELECTRICAL SHEET METAL | ThyssenKrupp Steel Europe AG (DE) | 2025-01-15 | — | — | EP | disclosed |
| EP-4432530-A2 | METHOD FOR PRODUCING A LAMINATED CORE, LAMINATED CORE AND ELECTRIC MACHINE | ThyssenKrupp Steel Europe AG (DE) | 2024-09-18 | — | — | EP | disclosed |
| EP-4418507-A2 | METHOD FOR PRODUCING A LAMINATED CORE, LAMINATED CORE AND ELECTRIC MACHINE | ThyssenKrupp Steel Europe AG (DE) | 2024-08-21 | — | — | EP | disclosed |
| EP-4404443-A1 | METHOD FOR PRODUCING A COMPOSITE MADE OF ELECTRICAL SHEETS | ThyssenKrupp Steel Europe AG (DE) | 2024-07-24 | — | — | EP | disclosed |
| WO-2024072822-A2 | DISPERSING AND WETTING AGENTS AND COMPOSITIONS AND METHODS OF USE THEREOF | MOJAVE BIO, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| US-20230380274-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-23 | — | — | US | disclosed |
| EP-1345911-A2 | PROCESS FOR PREPARING 2-METHOXY-4-METHYL-6-METHYLAMINO-1,3,5-TRIAZINE | Degussa AG (DE) | 2003-09-24 | — | — | EP | disclosed |
| US-20030166650-A1 | Cinnamide derivatives as KCNQ potassium channel modulators | BRISTOL-MYERS SQUIBB COMPANY | 2003-09-04 | — | — | US | disclosed |
| WO-2002096858-A1 | CINNAMIDE DERIVATIVES AS KCNQ POTASSIUM CHANNEL MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-12-05 | — | — | WO | disclosed |
| WO-2002051817-A3 | PROCESS FOR PREPARING 2-METHOXY-4-METHYL-6-METHYLAMINO-1,3,5-TRIAZINE | DEGUSSA (DE) | 2002-11-14 | — | — | WO | disclosed |
| WO-2002051817-A2 | PROCESS FOR PREPARING 2-METHOXY-4-METHYL-6-METHYLAMINO-1,3,5-TRIAZINE | DEGUSSA AG (DE) | 2002-07-04 | — | — | WO | disclosed |
| WO-2002051817-A2 | PROCESS FOR PREPARING 2-METHOXY-4-METHYL-6-METHYLAMINO-1,3,5-TRIAZINE | DEGUSSA AG (DE) | 2002-07-04 | — | — | WO | disclosed |
| US-6342600-B1 | Process for preparing 2-methoxy-4-methyl-6-methylamino-1,3,5-triazine | SKW T OSTBERG AKTIENGESELLSCHAFT (DE) | 2002-01-29 | — | — | US | disclosed |
| US-6342600-B1 | Process for preparing 2-methoxy-4-methyl-6-methylamino-1,3,5-triazine | SKW T OSTBERG AKTIENGESELLSCHAFT (DE) | 2002-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12427506-B1 | Method for carbon dioxide fixation using a palladium-doped nitrogen-rich organic framework catalyst | POF1B, CYP4F12, ETFB | ALDH1A1 810/4885GAA 4414/4885HSD17B10 1428/4885 |
| US-20230380274-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | TEAD2, TEAD3, TEAD4 | ALDH1A1 884/4885GAA 1829/4885HSD17B10 2209/4885 |
| US-20030166650-A1 | Cinnamide derivatives as KCNQ potassium channel modulators | KCNH2, KCNH3, KCNQ1 | ALDH1A1 2914/4885GAA 4501/4885HSD17B10 1492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.